Kasumi-1-engrafted mice survived longer regardless of treatment compared to FA-AML1-engrafted mice, likely due to the increased aggressiveness of FA-AML compared to non-FA-mutated AML. The gene discussed is RUNX1; the disease is acute myeloid leukemia.